Ono Pharmaceutical Co., Ltd.
OPHLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,230,726 | $138,991,000 | $204,567,000 | $160,982,000 |
| Short-Term Investments | $5,854 | $165,000 | $5,813,000 | $9,858,000 |
| Receivables | $939,701 | $143,540,000 | $135,022,000 | $152,211,000 |
| Inventory | $467,488 | $70,765,000 | $74,864,000 | $77,621,000 |
| Other Curr. Assets | $198,501 | $33,218,000 | $34,838,000 | $31,254,000 |
| Total Curr. Assets | $2,842,269 | $386,679,000 | $455,104,000 | $431,926,000 |
| Property Plant & Equip (Net) | $694,022 | $103,736,000 | $105,721,000 | $106,733,000 |
| Goodwill | $142,602 | $20,519,000 | $21,186,000 | $22,413,000 |
| Intangibles | $2,446,349 | $360,084,000 | $330,041,000 | $354,792,000 |
| Long-Term Investments | $657,079 | $89,706,000 | $88,558,000 | $110,937,000 |
| Tax Assets | $341,988 | $0 | $51,020,000 | $0 |
| Other NC Assets | $31,245 | $62,865,000 | $12,416,000 | $55,503,000 |
| Total NC Assets | $4,313,286 | $636,910,000 | $608,942,000 | $650,378,000 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,155,555 | $1,023,589,000 | $1,064,046,000 | $1,082,304,000 |
| Liabilities | – | – | – | – |
| Payables | $441,543 | $63,147,000 | $89,329,000 | $61,124,000 |
| Short-Term Debt | $221,944 | $32,862,000 | $33,178,000 | $33,005,000 |
| Tax Payable | $0 | $0 | $4,058,000 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $286,610 | $33,447,000 | $21,731,000 | $27,709,000 |
| Total Curr. Liab. | $950,098 | $129,456,000 | $148,296,000 | $121,838,000 |
| LT Debt | $659,661 | $105,249,000 | $113,500,000 | $121,281,000 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $34,611 | $0 | $10,817,000 | $0 |
| Other NC Liab. | $22,078 | $10,542,000 | $3,231,000 | $17,690,000 |
| Total NC Liab. | $716,350 | $115,791,000 | $127,548,000 | $138,971,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $51,261 | $10,611,000 | $11,678,000 | $11,786,000 |
| Total Liabilities | $1,666,448 | $245,247,000 | $275,844,000 | $260,809,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $117,340 | $17,358,000 | $17,358,000 | $17,358,000 |
| Retained Earnings | $5,506,290 | $789,980,000 | $790,908,000 | $791,609,000 |
| AOCI | $133,591 | $28,363,000 | $19,790,000 | $70,047,000 |
| Other Equity | -$306,296 | -$63,063,000 | -$45,605,000 | -$63,096,000 |
| Total Equity | $5,450,926 | $772,638,000 | $782,451,000 | $815,918,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $38,187 | $5,704,000 | $5,751,000 | $5,577,000 |
| Total Liab. & Tot. Equity | $7,155,561 | $1,023,589,000 | $1,064,046,000 | $1,082,304,000 |
| Net Debt | -$349,120 | -$880,000 | -$57,889,000 | -$6,696,000 |